These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Modulation of myo-[3H]inositol uptake by glucose and sorbitol in cultured bovine lens epithelial cells. I. Restoration of myo-inositol uptake by aldose reductase inhibition. Cammarata PR; Chen HQ; Yang J; Yorio T Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3561-71. PubMed ID: 1464502 [TBL] [Abstract][Full Text] [Related]
25. Reduced glomerular sodium/potassium adenosine triphosphatase activity in acute streptozocin diabetes and its prevention by oral sorbinil. Cohen MP; Dasmahapatra A; Shapiro E Diabetes; 1985 Nov; 34(11):1071-4. PubMed ID: 2995180 [TBL] [Abstract][Full Text] [Related]
26. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing. Greene DA Metabolism; 1986 Apr; 35(4 Suppl 1):60-5. PubMed ID: 2421135 [TBL] [Abstract][Full Text] [Related]
27. Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells. Part 1: A hypertonicity-induced protein enhances myo-inositol transport. Cammarata PR; Chen HQ Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1223-35. PubMed ID: 8125733 [TBL] [Abstract][Full Text] [Related]
28. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation. Yorek MA; Wiese TJ; Davidson EP; Dunlap JA; Stefani MR; Conner CE; Lattimer SA; Kamijo M; Greene DA; Sima AA Diabetes; 1993 Oct; 42(10):1401-6. PubMed ID: 8397126 [TBL] [Abstract][Full Text] [Related]
29. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. Greene DA; Lattimer SA Diabetes; 1984 Aug; 33(8):712-6. PubMed ID: 6086432 [TBL] [Abstract][Full Text] [Related]
30. The effect of elevated glucose levels on myo-inositol metabolism in cultured bovine aortic endothelial cells. Yorek MA; Dunlap JA Metabolism; 1989 Jan; 38(1):16-22. PubMed ID: 2491899 [TBL] [Abstract][Full Text] [Related]
31. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats. Berti-Mattera L; Day N; Peterson RG; Eichberg J Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638 [TBL] [Abstract][Full Text] [Related]
32. Glutathione redox state is not the link between polyol pathway activity and myo-inositol-related Na+-K+-ATPase defect in experimental diabetic neuropathy. Carroll PB; Thornton BM; Greene DA Diabetes; 1986 Nov; 35(11):1282-5. PubMed ID: 3019809 [TBL] [Abstract][Full Text] [Related]
33. Normalization of Na(+)-K(+)-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro. Kim J; Kyriazi H; Greene DA Diabetes; 1991 May; 40(5):558-67. PubMed ID: 1850704 [TBL] [Abstract][Full Text] [Related]
34. L-fucose is a potent inhibitor of myo-inositol transport and metabolism in cultured neuroblastoma cells. Yorek MA; Dunlap JA; Stefani MR; Davidson EP J Neurochem; 1992 May; 58(5):1626-36. PubMed ID: 1313850 [TBL] [Abstract][Full Text] [Related]
35. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819 [TBL] [Abstract][Full Text] [Related]
36. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications. Del Monte MA; Rabbani R; Diaz TC; Lattimer SA; Nakamura J; Brennan MC; Greene DA Diabetes; 1991 Oct; 40(10):1335-45. PubMed ID: 1936595 [TBL] [Abstract][Full Text] [Related]
37. Relation of Na+, K(+)-ATPase to delayed motor nerve conduction velocity: effect of aldose reductase inhibitor, ADN-138, on Na+, K(+)-ATPase activity. Hirata Y; Okada K Metabolism; 1990 Jun; 39(6):563-7. PubMed ID: 2161992 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study. Obrosova IG; Fathallah L Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083 [TBL] [Abstract][Full Text] [Related]
39. Non-competitive inhibition of myo-inositol transport in cultured bovine retinal capillary pericytes by glucose and reversal by Sorbinil. Li W; Chan LS; Khatami M; Rockey JH Biochim Biophys Acta; 1986 May; 857(2):198-208. PubMed ID: 3085711 [TBL] [Abstract][Full Text] [Related]
40. Restoration of Na(+)-K+ pump activity and resting membrane potential by myo-inositol supplementation in neuroblastoma cells chronically exposed to glucose or galactose. Yorek MA; Dunlap JA; Stefani MR Diabetes; 1991 Feb; 40(2):240-8. PubMed ID: 1846827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]